Allogeneic NK cells induce monocyte-to-dendritic cell conversion, control tumor growth, and trigger a pro-inflammatory shift in patient-derived cultures of primary and metastatic colorectal cancer
Elisa C. Toffoli(Amsterdam University Medical Centers), Tanja D. de Gruijl(Dutch Cancer Society), Amanda van Vliet, Jurriaan B. Tuynman(Amsterdam Neuroscience), Jan Spanholtz(AIMM Therapeutics (Netherlands)), Henk W M Verheul(Erasmus MC)
Cited by 21
Related Papers
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
|Radiology|2020|363
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
|The Lancet Oncology|2012|357
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
|The Lancet. Gastroenterology & hepatology|2019|326